p53, mdm-2, and p21 waf-1 in the porokeratoses

被引:13
作者
Nelson, C
Cowper, S
Morgan, M
机构
[1] James A Haley Vet Hosp, Dept Dermatopathol, Tampa, FL 33612 USA
[2] Univ S Florida, Coll Med, Dept Pathol, Tampa, FL 33620 USA
[3] Univ Missouri, Kansas City, MO 64110 USA
关键词
p53; mdm-2; p21; porokeratoses;
D O I
10.1097/00000372-199910000-00003
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
The etiology of the porokeratoses is unknown. Overexpression of the p53 tumor suppressor protein and disregulated cell cycle control have been pathogenically implicated. The p53 tumor suppressor gene product is regulated by mdm2 and both gene products influence cell cycle progression through the cyclin-dependent kinase inhibitor p21. Thirty-three cases of the various types of porokeratosis were immunohistochemically studied for p53, mdm2, and p21 proteins, Each of the cases showed increased p53 and decreased mdm2 and p21 expression within keratinocytes underlying cornoid lamella. This study confirms the previous findings of increased p53 staining and expands the potential roles of mdm2 and p21 in the pathogenesis of the porokeratoses.
引用
收藏
页码:420 / 425
页数:6
相关论文
共 30 条
[1]  
BERNASSI L, 1997, J INVEST DERMATOL, V109, P276
[2]  
CHERNOSKY ME, 1986, ARCH DERMATOL, V122, P853, DOI 10.1001/archderm.122.8.853
[3]  
CORDONCARDO C, 1995, AM J PATHOL, V147, P545
[4]  
DIGIUSEPPE JA, 1995, AM J PATHOL, V147, P884
[5]   ACTIVATION OF CDC2 PROTEIN-KINASE DURING MITOSIS IN HUMAN-CELLS - CELL-CYCLE DEPENDENT PHOSPHORYLATION AND SUBUNIT REARRANGEMENT [J].
DRAETTA, G ;
BEACH, D .
CELL, 1988, 54 (01) :17-26
[6]  
GOERTTLER EA, 1975, HUMANGENETIK, V26, P291
[7]   CARCINOGENESIS IN POROKERATOSIS - EVIDENCE FOR A ROLE RELATING TO CHRONIC GROWTH ACTIVATION OF KERATINOCYTES [J].
GRAY, MH ;
SMOLLER, BS ;
MCNUTT, NS .
AMERICAN JOURNAL OF DERMATOPATHOLOGY, 1991, 13 (05) :438-444
[8]  
Harris CC, 1996, JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS, VOL 1, NO 2, APRIL 1996, P115
[9]   CELL-CYCLE CONTROL AND CANCER [J].
HARTWELL, LH ;
KASTAN, MB .
SCIENCE, 1994, 266 (5192) :1821-1828
[10]   CYCLINS AND CANCER .2. CYCLIN-D AND CDK INHIBITORS COME OF AGE [J].
HUNTER, T ;
PINES, J .
CELL, 1994, 79 (04) :573-582